A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19).
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/05/200514131726.htm
No comments:
Post a Comment